Comparative analysis of vitamin D contents in patients with chronic viral hepatitis C and healthy.
DOI:
https://doi.org/10.26641/2307-0404.2019.4.189360Ключові слова:
monitoring, chronic hepatitis C, vitamin D deficiencyАнотація
From scientific literature it is known that vitamin D helps maintain the most important functions of the immune system, there is evidence of its role in inflammatory and metabolic diseases of the liver, including infection with hepatitis C. Aim – to study vitamin D status in patients with chronic viral hepatitis C compared to the healthy ones. We examined 100 patients with chronic viral hepatitis C (main group) and 30 patients without hepatitis C virus (control group). Level of 25 (OH) D in serum was studied by immunochemical method with electrochemiluminescent detection. To verify the diagnosis of vitamin D deficiency and insufficiency, a classification (M.F. Holick, 2011), adopted by the International Institute of Medicine and the Committee of Endocrinologists for clinical practice guidelines, was used. Vitamin D deficiency was found in 44% of people with chronic viral hepatitis C in the main group (mean hydroxycalciferol – 14.36±4.12 ng/ml. Vitamin D deficiency was found in 6,6% in the control group (mean 17,5±8,52 ng/ml). The average vitamin D deficiency in the main group was slightly lower than that in the control group. Factors that affect the metabolism of vitamin D in patients with chronic viral hepatitis C include a lack of vitamin D in blood serum.
Посилання
Sergeev IN, Pletsyt KD, Spirichev FI. Receptors of 1,25-dihydroxyvitamin D3 in lymphocytes and the level of T- and B-lymphocytes in patients with glomerulonephritis. Questions of medical chemistry. 1989;36(6):117-21.
Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq-defined genome-wide map of vitamin D receptor binding: аassociations with disease and evolution. Genome Research. 2010;20(10):1352-60. doi: https://doi.org/10.1101/gr.107920.110
Brumbaugh PF, Hausler MR. 1a, 25-dihydroxycholecalciferol receptor in intestine. Association with intestinal mucosa chromatin. J. Biol. Chem. 1974;242(4):1251-7.
Clohisy DR, Bar-Schavit Z, Chappel JC, Teitelbaums SL. 1,25-dihydroxyvitamin D modulates bonemazzow macrophage precursor proliferation and differentiation. J. Biol. Chem. 1987;262(33):15922-29.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2011;96(7):1911-30.
Gao L, Tao Y, Zhang L. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and metaanalysis. Int. J. Tuberc. Lung Dis. 2010;14(1):15-23.
Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin endocrine system. Cell. Mol. Biol. 2003;49(2):277-300.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81. PubMed. Google Scholar. doi: https://doi.org/10.1056/NEJMra070553
Morgan JM, Konttab N, Ford AL. Mairel Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology. 2000;141(9):3225-34. doi: https://doi.org/10.1210/en.141.9.3225
Berer A, Stockl J, Majdic O, et al. 1,25-dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol. 2000;28(5):575-583. doi: https://doi.org/10.1016/S0301-472X(00)00143-0
Pang Q, Qu K, Zhang J-Y, Liu C. Evidence supporting a beneficial role of vitamin D in chronic hepatitis C, Journal of Hepatology; 2015. doi: http://dx.doi.org/10.1016/j.jhep.2015.03.037
Penna G, Adorini L. 1 alfa, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation. J. Immunol. 2000;164(5):2405-11. doi: https://doi.org/10.4049/jimmunol.164.5.2405
Pizas JE, Turner RT, Howard GA, Baylink DJ. Cell isolated from embryonic intestinal synthesizes 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in culture. Endocrinolody. 1983;112(1):378-380. doi: https://doi.org/10.1210/endo-112-1-378
Takuya M, Takanobu K, Nao S, Megumi T, Asako M, Takahiro M, et al. 25-hydroxyvitamin D3 suppresses hepatitis C virus production. J. Hepatol. 2012;56:1231-9. doi: https://doi.org/10.1002/hep.25763
Villar LM, Del Campo JA, Ranchal I. Association between vitamin D and hepatitis C virus infection: a meta-analysis. World J. Gastroenterol. 2013;19(35):5917-24. doi: https://doi.org/10.3748/wjg.v19.i35.5917
Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A. et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transplant. Int. 2010;24:43-50. doi: https://doi.org/10.1111/j.1432-2277.2010.01141.x
Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation and faction of human monocyte derived dendritie cells. J. Immunol. 2000;164(9):4443-51. doi: https://doi.org/10.4049/jimmunol.164.9.4443
Yamshchikov AV, Desai N, Blumberg H. Vitamin D for treatment and prevention of infectious diseases: asystematic review of randomized controlled trials. Endocr. Pract. 2009;15:(5):438-49. doi: doi.org/10.4158/EP09101.ORR
##submission.downloads##
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2019 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
